Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
276 GBX | -0.36% |
|
-2.13% | -2.47% |
Jun. 25 | Takeda's Cancer Drug Gets European Commission Approval | MT |
Jun. 24 | Hutchmed China notes Takeda obtains EU approval for Fruzaqla | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.47% | 2.99B | |
+56.61% | 819B | |
-6.44% | 351B | |
+18.46% | 329B | |
+9.54% | 298B | |
+16.57% | 242B | |
+2.04% | 225B | |
+13.31% | 217B | |
+8.26% | 168B | |
-2.99% | 158B |
- Stock Market
- Equities
- HCM Stock
- News HUTCHMED (China) Limited
- Hutchmed (China), Takeda Secure EU Approval for Colorectal Cancer Treatment